Aims: To study the β-adrenoceptor subtypes involved in the relaxation responses to (-)-isoprenaline in carbachol-pre-contracted (CCh) mouse detrusor muscle with intact and denuded mucosa. Methods: Isolated muscle strips from the urinary bladder of male C57BL6 mice or β2-adrenoceptor knockout mice were pre-contracted with CCh, 1 µ<smlcap>M</smlcap> and relaxed with increasing concentrations of the β-adrenoceptor (β-AR) agonist (-)-isoprenaline and forskolin. For estimating the β-AR subtypes involved, subtype-selective receptor blockers were used, that is, CGP 20712A (β1-ARs), ICI 118,551 (β2-ARs), and L748,337 (β3-ARs). Results: Unlike in KCl-pre-contracted muscle, the mucosa did not affect the sensitivity of the relaxation response to (-)-isoprenaline in CCh-pre-contracted murine detrusor strips. Increasing concentrations of (-)-isoprenaline produced a biphasic concentration-relaxation response without any difference both during the presence and absence of mucosa. The relaxation fraction produced by low (-)-isoprenaline concentrations was mediated by β2-AR as evidenced by a shift of the concentration-response curve to higher concentrations with ICI 118,551, but not with CGP 20712A and L748,337, and by the absence of this fraction in β2-AR-KO mice. The relaxation response with low sensitivity to (-)-isoprenaline was not affected by any of the β-AR subtype-selective blockers and was the only response detected in detrusor strips from β2-AR-KO mice. Conclusions: In CCh-pre-contracted mouse detrusor, β2-ARs are responsible for the relaxation component with high sensitivity to (-)-isoprenaline as indicated by the conversion of a biphasic into a monophasic CRC with ICI 118,551 or by its absence in β2-AR KO mice. The mucosa does not impair relaxation under these conditions.

Journal Section:
Editor's choice
Keywords:
Detrusor smooth muscle, Carbachol-induced contractions, Relaxation, Mucosa, &#0946;-Adrenoceptors
1.
Birder LA, Ruggieri M, Takeda M, van Koeveringe G, Veltkamp S, Korstanje C, Parsons B, Fry CH: How does the urothelium affect bladder function in health and disease? ICI-RS 2011. Neurourol Urodyn 2012;31:293-299.
[PubMed]
https://doi.org/10.1002/nau.22195
2.
Khandelwal P, Abraham SN, Apodaca G: Cell biology and physiology of the uroepithelium. Am J Physiol Renal Physiol 2009;297:F1477-F1501.
[PubMed]
https://doi.org/10.1152/ajprenal.00327.2009
3.
Propping S, Newe M, Kaumann AJ, Wirth MP, Ravens U: Mucosa of murine detrusor impairs beta2 -adrenoceptor-mediated relaxation. Neurourol Urodyn 2014, Epub ahead of print.
4.
Propping S, Wuest M, Eichhorn B, Wirth MP, Kaumann AJ, Ravens U: Mucosa of human detrusor impairs contraction and beta-adrenoceptor-mediated relaxation. BJU Int 2013;112:1215-1222.
[PubMed]
https://doi.org/10.1111/bju.12267
5.
Chaiyaprasithi B, Mang CF, Kilbinger H, Hohenfellner M: Inhibition of human detrusor contraction by a urothelium derived factor. J Urol 2003;170:1897-1900.
[PubMed]
https://doi.org/10.1097/01.ju.0000091870.51841.ae
6.
Andersson KE, Arner A: Urinary bladder contraction and relaxation: physiology and pathophysiology. Physiol Rev 2004;84:935-986.
[PubMed]
https://doi.org/10.1152/physrev.00038.2003
7.
Hawthorn MH, Chapple CR, Cock M, Chess-Williams R: Urothelium-derived inhibitory factor(s) influences on detrusor muscle contractility in vitro. Br J Pharmacol 2000;129:416-419.
[PubMed]
https://doi.org/10.1038/sj.bjp.0703068
8.
Levin RM, Wein AJ, Krasnopolsky L, Atta MA, Ghoniem GM: Effect of mucosal removal on the response of the feline bladder to pharmacological stimulation. J Urol 1995;153:1291-1294.
[PubMed]
https://doi.org/10.1016/S0022-5347(01)67587-6
9.
Maggi CA, Santicioli P, Parlani M, Astolfi M, Patacchini R, Meli A: The presence of mucosa reduces the contractile response of the guinea-pig urinary bladder to substance P. J Pharm Pharmacol 1987;39:653-655.
[PubMed]
https://doi.org/10.1111/j.2042-7158.1987.tb03447.x
10.
Masunaga K, Chapple CR, McKay NG, Yoshida M, Sellers DJ: The beta3-adrenoceptor mediates the inhibitory effects of beta-adrenoceptor agonists via the urothelium in pig bladder dome. Neurourol Urodyn 2010;29:1320-1325.
[PubMed]
https://doi.org/10.1002/nau.20838
11.
Murakami S, Chapple CR, Akino H, Sellers DJ, Chess-Williams R: The role of the urothelium in mediating bladder responses to isoprenaline. BJU Int 2007;99:669-673.
[PubMed]
https://doi.org/10.1111/j.1464-410X.2006.06679.x
12.
Otsuka A, Shinbo H, Matsumoto R, Kurita Y, Ozono S: Expression and functional role of beta-adrenoceptors in the human urinary bladder urothelium. Naunyn Schmiedebergs Arch Pharmacol 2008;377:473-481.
[PubMed]
https://doi.org/10.1007/s00210-008-0274-y
13.
Wuest M, Eichhorn B, Grimm MO, Wirth MP, Ravens U, Kaumann AJ: Catecholamines relax detrusor through beta 2-adrenoceptors in mouse and beta 3-adrenoceptors in man. J Pharmacol Exp Ther 2009;328:213-222.
[PubMed]
https://doi.org/10.1124/jpet.108.142562
14.
Chruscinski AJ, Rohrer DK, Schauble E, Desai KH, Bernstein D, Kobilka BK: Targeted disruption of the beta2 adrenergic receptor gene. J Biol Chem 1999;274:16694-16700.
[PubMed]
https://doi.org/10.1074/jbc.274.24.16694
15.
Herrera GM, Heppner TJ, Nelson MT: Regulation of urinary bladder smooth muscle contractions by ryanodine receptors and BK and SK channels. Am J Physiol Regul Integr Comp Physiol 2000;279:R60-R68.
[PubMed]
16.
Sibley GN: A comparison of spontaneous and nerve-mediated activity in bladder muscle from man, pig and rabbit. J Physiol 1984;354:431-443.
[PubMed]
https://doi.org/10.1113/jphysiol.1984.sp015386
17.
Noronha-Blob L, Lowe V, Patton A, Canning B, Costello D, Kinnier WJ: Muscarinic receptors: relationships among phosphoinositide breakdown, adenylate cyclase inhibition, in vitro detrusor muscle contractions and in vivo cystometrogram studies in guinea pig bladder. J Pharmacol Exp Ther 1989;249:843-851.
[PubMed]
18.
Longhurst PA, Levendusky M: Pharmacological characterization of beta-adrenoceptors mediating relaxation of the rat urinary bladder in vitro. Br J Pharmacol 1999;127:1744-1750.
[PubMed]
https://doi.org/10.1038/sj.bjp.0702709
19.
Michel MC, Sand C: Effect of pre-contraction on beta-adrenoceptor-mediated relaxation of rat urinary bladder. World J Urol 2009;27:711-715.
[PubMed]
https://doi.org/10.1007/s00345-009-0416-y
20.
Ehlert FJ, Ahn S, Pak KJ, Park GJ, Sangnil MS, Tran JA, Matsui M: Neuronally released acetylcholine acts on the M2 muscarinic receptor to oppose the relaxant effect of isoproterenol on cholinergic contractions in mouse urinary bladder. J Pharmacol Exp Ther 2007;322:631-637.
[PubMed]
https://doi.org/10.1124/jpet.107.121756
21.
Hedge BM: Calcium channel blockers - under a cloud? J Indian Med Assoc 1997;95:569-570.
[PubMed]
22.
Frazier EP, Mathy MJ, Peters SL, Michel MC: Does cyclic AMP mediate rat urinary bladder relaxation by isoproterenol? J Pharmacol Exp Ther 2005;313:260-267.
[PubMed]
https://doi.org/10.1124/jpet.104.077768
23.
Deba A, Palea S, Rouget C, Westfall TD, Lluel P: Involvement of beta(3)-adrenoceptors in mouse urinary bladder function: role in detrusor muscle relaxation and micturition reflex. Eur J Pharmacol 2009;618:76-83.
[PubMed]
https://doi.org/10.1016/j.ejphar.2009.07.012
24.
Cernecka H, Sand C, Michel MC: The odd sibling: features of beta3-adrenoceptor pharmacology. Mol Pharmacol 2014;86:479-484.
[PubMed]
https://doi.org/10.1124/mol.114.092817
© 2015 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2015
You do not currently have access to this content.